Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

CVRx, Inc. (CVRX) Cash Flow Statement

CVRx, Inc. (CVRX) generated -$40.5M of operating cash flow over the twelve months to 2026-06-30, spent $597000 on capital expenditure and had free cash flow of -$41.1M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CVRXCVRx, Inc.Follow CVRX — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
37.8M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
3 Nov, in 10 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-27.7-42.7-39.0-39.1-40.2-40.5
Capital expenditure1.20.70.61.40.6-0.6
Free cash flow-28.9-43.4-39.6-40.5-40.8-41.1
Stock-based compensation1.93.96.319.111.1—

USD millions · SEC XBRL

CVRx, Inc. — questions

What is CVRx, Inc.'s operating cash flow?
-$40.5M over the twelve months to 2026-06-30.
How much does CVRx, Inc. spend on capital expenditure?
$597000 over the twelve months to 2026-06-30.
What is CVRx, Inc.'s free cash flow?
-$41.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from CVRx, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.